The measurement of the partial pressure of carbon dioxide in the arterial blood (PaCO 2 determine the adequacy of ventilation and to guide changes in mechanical ventilation. Although arterial sampling provides this information, frequent arterial blood gas (ABG) analysis is expensive, time restrictive and provides only intermittent data for what may be a rapidly changing value. To overcome such problems, noninvasive monitors are frequently used to provide a continuous estimate of the PaCO 2 room, end-tidal (ET) CO 2 provides a better estimate of PaCO 2 patients undergoing VATS. ) is used to . In the operating monitoring remains the 0.6280 and a slope = 0.7650 ± 0.1428, while linear regression analysis of ET-CO 2 vs. PaCO 2 resulted in an r 2 = 0.05528 and a slope = 0.1986 ± 0.1883. During OLV, the difference between the TC-CO 2 and PaCO 2 was 3.5 ± 1.7 mmHg and the ET-CO 2 to PaCO 2 difference was 9.6 ± 3.6 mmHg (P=0.03 vs. ET-CO 2 to PaCO 2 difference during TLV; and P<0.0001 vs. TC-CO 2 to PaCO 2 difference during OLV). In 13 of the 15 patients, the TC-CO 2 value was closer to the actual PaCO 2 than the ET-CO 2 value (P=0.0001). Linear regression analysis of TC CO 2 vs. PaCO 2 resulted in an r 2 = 0.7827 and a slope = 0.8142 ± 0.0.07965, while linear regression analysis of ET-CO 2 vs. PaCO 2 resulted in an r 2 = 0.2989 and a slope = 0.3026 ± 0.08605. Conclusions: During OLV, TC-CO 2 monitoring standard of care for continuous and noninvasive PaCO 2 monitoring. However, various factors, including patient positioning, sampling errors and ventilationperfusion mismatch due to dead space or shunt, may significantly affect the arterial to ET-CO 2 gradient. One-lung ventilation (OLV) is commonly used during thoracic surgery to allow surgical access to the operative lung and to eliminate lung movement during ventilation. The technique is helpful during open thoracic procedures and a necessity for minimal access thoracoscopic procedures. During OLV, the bronchus of the affected lung is occluded by a bronchial blocker or isolated by a double-lumen endotracheal tube, with oxygenation and ventilation supported by the nonoperative lung. Even with effective hypoxic pulmonary vasoconstriction, the technique results in an increase in the shunt fraction and perfusion of the nonventilated lung. Previous studies have demonstrated a significant arterial to ET-CO 2 gradient during one-lung OLV.
[4-6] The efficacy of ET-CO 2 monitoring is limited during such proce dures, suggesting that alternative noninvasive mon trode. Prior to placement, the sensor was prepared and calibrated according to the manufacturer's rec ommendations. The sensor is calibrated in vitro by using a one-point dry gas calibration with 7% carbon dioxide. The working temperature of the sensor is 42°C. The sensor was cleaned with alcohol and dried before application. One drop of contact gel was ap plied to the center of the sensor prior to placement on the patient's earlobe. Oxygen saturation values itors of PaCO 2 may be needed. Although used preare available immediately, while TC-CO 2 dominantly in the neonatal and pediatric population, available after a 2-3 min calibration time. there is increasing interest in the use of and recent reports of transcutaneous (TC) CO 2 monitoring in the Data collection and statistical analysis adult population.
[5-9] The current study prospectively ABG analyses were obtained following endotracheal compares ET-CO 2 and TC-CO 2 monitoring during OLV intubation during two-lung ventilation (TLV) and as in adults undergoing video-assisted thoracoscopic clinically indicated during OLV obtained, the ET-CO 2 and TC-CO 2 recorded on a data sheet. Calculation of the absolute
MATERIALS AND METHODS
difference between the noninvasive monitor (ET-CO 2 or TC-CO 2 ) and the PaCO 2 was performed. Negative The study was approval by the Institutional Review numbers were not used because this could artificially Board and the Committee for the Protection of Human lower the mathematical mean of the differences Subjects of the University of Missouri. Verbal informed between the noninvasive monitors of CO 2 consent was obtained from each patient. The patient PaCO 2 . If multiple ABGs were obtained during OLV, population included patients scheduled for minimal the absolute differences between the PaCO 2 access thoracic surgery and OLV, who were 18 years noninvasive monitors were averaged and counted as of age or older and in whom intraarterial access was a single data point. This was done to avoid biasing deemed necessary. OLV was provided by either a the data by overrepresentation of any one patient as bronchial blocker or a double lumen endotracheal the number of ABGs varied for each patient. The tube. Effective lung separation was confirmed by absolute difference between the ET-CO 2 clinical auscultation and fiberoptic bronchoscopy prior was compared to the absolute difference between the to the start of the procedure. Intrathoracic CO 2 TC-CO 2 and the PaCO 2 during TLV and OLV using a insufflation was not used during the procedure.
non Transcutaneous and end-tidal carbon dioxide monitoring ET-CO 2 was measured using an infrared analyzer with a side stream sampler attached at the elbow between the endotracheal tube and the anesthesia circuit. Prior to use, the ET-CO 2 device was calibrated according to the manufacturer's recommendations. TC-CO 2 was measured with a commercially available TC-CO 2 device (Sentec AG, Therwil, Switzerland). This device is based on a Stow-Severinghaus-type CO 2 sensor combined with a pulse oximeter and is attached to the patient's earlobe by a low pressure attachment clip. [10, 11] The in vitro 90% response time is <50s for the CO 2 elec exact test was used to compare the times that each of the noninvasive monitors was closest to the actual PaCO 2 . Using the raw numbers from all of the individual sample sets (PaCO 2 /ET-CO 2 /TC-CO 2 ) obtained during TLV and OLV, linear regression analysis and Bland-Altman analyses were performed.
RESULTS
The cohort for the study included 15 patients ranging in age from 19 to 71 years (46.9 ± 17.3 years) and in weight from 76 to 126 kg (93.4 ± 12.4 kg). There were 11 men and 4 women. Nineteen sample sets (PaCO 2 /ET-CO 2 /TC-CO 2 ) were obtained during TLV and 27 were obtained during OLV. During TLV, the differ ence between the TC-CO 2 and the PaCO 2 was 3.0 ± 1.8 mmHg with a range of 0 to 8 mmHg and the difference between the ET-CO 2 and the PaCO 2 was 6.2 ± 4.7 mmHg with a range of 2 to 18 mmHg (P= 0.02 vs. TC-CO 2 to PaCO 2 difference) [ Table 1 ]. During TLV, the TC-CO 2 value was closer to the actual PaCO 2 in 10 patients, the ET-CO 2 value was closer in 2 patients and there was no difference in 3 patients and a precision of ± 5.5 mmHg.
During OLV, the difference between the TC-CO 2 and the PaCO 2 was 3.5 ± 1.7 mmHg with a range of 2 to 8 mmHg (P= NS vs. TC-CO 2 to PaCO 2 difference during TLV). During OLV, the ET-CO 2 to PaCO 2 difference was 9.6 ± 3.6 mmHg with a range of 2 to 15 mmHg (P= 0.03 vs. ET-CO 2 to PaCO 2 difference during TLV; and P< 0.0001 vs. TC-CO 2 to PaCO 2 difference during OLV) Cox, et al.: Noninvasive carbon dioxide monitoring bias of + 2.9 mmHg and a precision of ± 2.5 mmHg and analysis of ET vs. PaCO 2 revealed a bias of -10.5 mmHg and a precision of ± 6.2 mmHg.
No problems occurred with ET-CO 2 monitoring dur ing the study period. In two patients, the TC-CO 2 elec trode had to be repositioned after the initial place ment to obtain an effective value. No blistering, erythema or skin changes were noted on the earlobe
In addition to these factors, the significant physio logic alterations induced by OLV can be expected to alter the relationship between ET-CO 2 and PaCO 2 val ues. Ip Yam et al evaluated the accuracy of ET-CO 2 during OLV in a cohort of 22 adults undergoing tho racotomy.
[4] During TLV, the ET-CO 2 to PaCO 2 differ ence was 1.3 ± 0.6 kPa (1 kPa = 7.5 mmHg) and it was 1.2 ± 0.7 kPa during OLV. Even if the difference for subsequent ABG analysis was corrected by subfollowing use of the TC-CO 2 device.
tracting the gradient from the first ABG analysis, the ET-CO 2 to PaCO 2 difference varied from -1.3 to 1.7 kPa. The authors concluded that the efficacy of ET CO 2 monitoring during OLV even when using correctThe current study demonstrates that noninvasive ed values remains questionable. monitoring of PaCO 2 using ET-CO 2 devices may be inaccurate during minimal access thoracoscopic Two previous studies have evaluated noninvasive surgery and OLV in adults. In our cohort of 15 patients, PCO 2 monitoring during OLV using both TC-CO 2 monitoring was more accurate than ET-CO 2 ET-CO 2 devices in patients undergoing open monitoring (difference of 3.0 ± 1.8 mmHg vs. 6.2 ± thoracotomy, [5, 6] while there are no previous reports 4.7 mmHg) during the baseline state using TLV. of using such monitoring in patients undergoing Although no significant change was noted in the TCminimal access surgery. Oshibuchi et al compared gradient during OLV (3.5 ± 1.7 mmHg), the accuracy of TC-CO 2 and ET-CO 2 to PaCO 2 difference increased to 9.6 ± 3.6 cohort of 26 adult patients undergoing OLV for open mmHg. In 13 of 15 patients, the TC-CO 2 was closer thoracotomy and pneumonectomy. The transcuta to the actual PaCO 2 than the ET-CO 2 during OLV.
neous device (TCM3 transcutaneous CO 2 vice, Radiometer, Copenhagen, Denmark) was Several factors may be responsible for discrepancies applied to the upper part of the patient's dependent between ET-CO 2 and PaCO 2 , including technical issues arm. Evaluation of the TC-CO 2 with the monitor; and patient-related factors, revealed a bias of -0.4 mmHg and a precision of ± including ventilation-perfusion mismatch, dead space 2.5 mmHg during TLV and a bias of 1.4 mmHg and and true shunt. [12, 13] Whitesell et al demonstrated that a precision of ± 4.3 mmHg during OLV. Evaluation patients with underlying lung disease had a of the ET-CO 2 to PaCO 2 difference revealed a bias of significantly greater ET-CO 2 to PaCO 2 gradient when -5.8 mmHg and a precision of ± 4.1 mmHg during DISCUSSION -and TC-CO 2 CO 2 to PaCO 2 monitoring in a the ET-CO 2 /oxygen de to PaCO 2 difference compared with patients with normal baseline pulmonary function (3.3 ± 0.6 mmHg versus 0.8 ± 0.3 mmHg).
[13] Patient positioning has also been shown to have an impact on the accuracy of ET-CO 2 monitoring.
[2,3] With patients undergoing renal or upper ureteral surgery in the supine position, Pansard et al reported that the ET-CO 2 to PaCO 2 difference was 4.8 ± 3.9 mmHg 10 min after induction and increased to 7.9 ± 3.5 mmHg (P<0.01) 5 min after placement of the patients into the lateral decubitus 'kidney rest' position. Similar results were reported by Grenier et al in a cohort of patients undergoing neurosurgical procedures in the lateral decubitus position.
[3]
TLV and a bias of -7.1 mmHg and a precision of ± 4.6 mmHg during OLV. The authors concluded that TC-CO 2 monitoring was an accurate means of evaluating PaCO 2 during OLV. Tobias et al used the same transcutaneous device in their study of 15 young adult and pediatric patients (14.1 ± 6.1 years, range -5 to 28 years) undergoing open thoracotomy.
[5] During TLV, the TC-CO 2 to PaCO 2 difference was 2.5 ± 0.8 mmHg, while the ET-CO 2 to PaCO 2 difference was 3.9 ± 1.6 mmHg (P= 0.0049). There was a significant increase in the ET CO 2 to PaCO 2 gradient during OLV (5.8 ± 2.3 mmHg), while no change was noted in the TC-CO 2 to PaCO 2 difference (2.7 ± 1.4 mmHg). The previously reviewed studies of Oshibuchi et al and Tobias, along with the data from the current co hort of adult patients, demonstrate the inaccuracy of ET-CO 2 monitoring during OLV and suggest that TC CO 2 monitoring is an effective alternative or adjunct. Until recently, transcutaneous CO 2 monitoring was used most commonly in the neonatal and occasion ally in the pediatric ICU population; however, there is growing experience with its use in adult patients infrared sensor, pH electrode or a Clark-type electrode.
[21] Unlike ET-CO 2 , which typically underestimates actual CO 2 , the transcutaneous method typically overestimates actual CO 2 by 5.2 6.4 mmHg due to the increased CO 2 production from local metabolism induced by heating to 42°C. The currently available TC-CO 2 devices have an internal correction / calibration factor to correct for the heatinduced changes in CO 2 production. TC-CO 2 in both the operating room and the ICU setting.
[7-9, [14] [15] [16] monitoring requires specific training in calibration, These studies have demonstrated that TC-CO 2 is more preparation, placement and maintenance of the accurate than ET-CO 2 in situations where the contindevice. Errors in any one of these steps may give false uous monitoring of PaCO 2 is vital.
readings. When compared with ET-CO 2 currently available TC-CO 2 monitors require a longer monitoring may be of particular benefit when preparation time, including a 5-min calibration peri the ventilation-perfusion properties of the respiratory od and then an additional 5-10 min equilibration time system are altered. ET-CO 2 measures a sample of gas after placement on the patient. Although not an isthat contains a mixture of gas exhaled from several sue with the TC-CO 2 monitor used in the current study, areas of the airway and alveoli. Regions with a high other TC-CO 2 monitors may require heating the skin ventilation-perfusion ratio (dead space) do not to 44-45°C to ensure accuracy. When this is done, participate in gas exchange and therefore the partial there are occasional reports of superficial burns and pressure of CO 2 is low or absent. During exhalation, skin blistering. Technical and patient-related factors the gas from regions of dead space mixes with the may affect the accuracy of TC-CO 2 gas from areas of normal ventilation-perfusion ratios, proper membrane placement on the sensor or damresulting in dilution of the ET-CO 2 sample and a age to the membrane may affect its accuracy. Patient widening of the ET-CO 2 to PaCO 2 difference.
factors, including skin thickness, skin edema and Alternatively, areas of low ventilation-perfusion ratios hypoperfusion (decreased cardiac output, hypovolem (shunt) result in ineffective gas exchange and the ia or vasoconstriction), may also alter the diffusion addition of blood with a high partial pressure of CO 2 of CO 2 to the sensor and result in inaccurate readto the arterial circulation contributing to the ings. [22] [23] [24] As no continuous noninvasive monitor can increased ET-CO 2 to PaCO 2 gradient. [17] [18] be expected to be 100% accurate, periodic calibra tion with an arterial sample may be indicated. monitoring avoids the effect of sampling gas monitoring, TC-CO 2 monitoring. Im-TC-CO 2 that may be subject to ventilation-perfusion mismatch. Transcutaneous monitoring relies on cutaneous respiration of the diffusion of gases across the skin. The transcutaneous monitor measures the CO 2 that is produced by local tissue metabolism and the CO 2 released from the blood as it flows through the capillaries near the skin surface. The latter is in direct equilibrium with the capillary CO 2 which is in equilibrium with the arterial CO 2 . Warming of the skin to 42°C by the sensor increases blood flow and CO 2 solubility, resulting in an even greater diffusion of CO 2 into the skin and equilibration with capillary and arterial PCO 2 values. [19, 20] The TC-CO 2 monitor measures the PCO 2 at the epidermis by using an
CONCLUSION
The current study adds to the growing body of knowl edge demonstrating the efficacy of TC-CO 2 monitor ing in the adult population. This study is the first to evaluate the use of TC-CO 2 vs. ET-CO 2 during OLV in minimal access surgery. The continuous monitoring of PaCO 2 may be particularly important during mini mal access surgery. In addition to OLV, CO 2 insuffla tion, to facilitate surgical visualization, places pa tients at a higher risk of hypercarbia than those undergoing open procedures. The combination of increased CO 2 from systemic absorption of the insufflated CO 2 with alterations in tidal volume imposed by decreasing minute ventilation during OLV makes accurately and continuously monitoring PaCO 2 vital during minimal access surgery. TC-CO 2 monitoring is not meant to replace ET-CO 2 monitoring. Rather, the devices should be used to complement one another, especially in the OR setting.
Although our data further demonstrate that TC-CO 2 monitoring is more accurate than ET-CO 2 monitoring, ET-CO 2 remains the standard of care in the OR to
